Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Opinion & Analysis Cybin Inc. N.CYBN

Alternate Symbol(s):  CYBN

Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders, all protected under its ever-growing IP portfolio.


Opinion & Analysis (NEO:CYBN)

    A Company on a Mission to Revolutionize Mental Healthcare. Here’s How.

    Dave Jackson February 1, 2022

    The Psychedelic Opportunity You Need to Know About

    Dave Jackson October 20, 2021

    Revolutionizing Mental Health Treatment

    Featured Submission August 16, 2021

    A New Frontier in Psychedelic Therapeutics

    Featured Submission January 12, 2021

    A Psychedelic & Nutraceutical Opportunity: A Boost for the Brain and Your Portfolio

    Dave Jackson September 22, 2020